Outcomes of drug-coated balloon urethral dilation in patients with stricture recurrence after urethroplasty
DCB dilation was effective for treatment of urethral stricture recurrence after urethroplasty at a median follow-up of 228 days in our cohort. This minimally invasive intervention may be an option for patients who are not ideal surgical candidates or refuse repeat urethroplasty. Data on longer-term outcomes in this cohort is needed and is forthcoming.
Authors
- Lawrence L. Yeung (ORCID: https://orcid.org/0000-0002-4801-8790)
- Elizabeth P. Kwenda (ORCID: https://orcid.org/0000-0001-8166-624X)
- Ramzy T. Burns (ORCID: https://orcid.org/0009-0005-6610-4560)
- Ashorne K. Mahenthiran (ORCID: https://orcid.org/0000-0003-3409-2460)
- Matthew J. Mellon (ORCID: https://orcid.org/0000-0003-4823-4503)
Institutions
- University of Florida (US)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Translational Andrology and Urology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.21037/tau-2025-49
- Primary Topic
- Urological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00